Combination therapy in severe Acinetobacter baumannii infections: an update on the evidence to date.
about
Biofilm-associated proteins: news from Acinetobacter.Molecular characterization and antimicrobial susceptibility of Acinetobacter baumannii isolates obtained from two hospital outbreaks in Los Angeles County, California, USAGraphene oxide-silver nanocomposite as a promising biocidal agent against methicillin-resistant Staphylococcus aureus.The Effect of Colistin Resistance-Associated Mutations on the Fitness of Acinetobacter baumannii.Spread of the blaOXA-23-Containing Tn2008 in Carbapenem-Resistant Acinetobacter baumannii Isolates Grouped in CC92 from China.Synergy between Colistin and the Signal Peptidase Inhibitor MD3 Is Dependent on the Mechanism of Colistin Resistance in Acinetobacter baumannii.Widespread dispersion of the resistance element tet(B)::ISCR2 in XDR Acinetobacter baumannii isolates.Postantibiotic effect of colistin alone and combined with vancomycin or meropenem against Acinetobacter spp. with well defined resistance mechanisms.Molecular mechanisms of sulbactam antibacterial activity and resistance determinants in Acinetobacter baumannii.Frequency of bap and cpaA virulence genes in drug resistant clinical isolates of Acinetobacter baumannii and their role in biofilm formation.Bioanalytical method validation for the simultaneous determination of ceftazidime and avibactam in rat plasma.
P2860
Q35842389-E541F786-7595-4F71-8AD9-01F29DC69CDBQ36008636-FA7D0EFD-5ED0-4565-8CD2-AF8F2E535BC0Q36257260-3FC38993-738A-4EE0-B9DA-F71FD23BE036Q37382368-D613255F-335D-4AD2-99B5-E577B93A6092Q37625333-9584AD94-463C-4654-9D37-87687EA201AEQ40690118-DCE390E6-A493-4F25-BEE8-E1FE52D685E9Q40903750-A60FE4FB-1A75-4741-BB96-C059AC7E3226Q41026343-AFF2978A-4591-437E-A280-EED7593E5385Q41561999-A152F2BF-31DF-4DB3-93CC-EBE57C15EA1EQ46007524-AA5BEB09-841F-4041-A665-99BC45A377A9Q50903796-B055CF5E-EAF2-4789-B02C-685545AF746D
P2860
Combination therapy in severe Acinetobacter baumannii infections: an update on the evidence to date.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Combination therapy in severe ...... pdate on the evidence to date.
@en
type
label
Combination therapy in severe ...... pdate on the evidence to date.
@en
prefLabel
Combination therapy in severe ...... pdate on the evidence to date.
@en
P2860
P356
P1433
P1476
Combination therapy in severe ...... pdate on the evidence to date.
@en
P2093
Riccardo Utili
P2860
P304
P356
10.2217/FMB.14.34
P577
2014-01-01T00:00:00Z